08 Jun Antibiotic Impregnated Catheters Can Reduce Central Line-Associated Bloodstream Infection
MedicalResearch.com Interview with:
Stephanie Bonne, MD, FACS
Assistant Professor
Trauma, Acute, and Critical Care Surgery
Washington University in St. Louis
Medical Research: What is the background for this study? What are the main findings?
Response: We had previously implemented education programs in our ICU in an attempt to decrease our Central Line-Associated Bloodstream Infection (CLABSI) rate. We were, however, unable to come to zero. We were looking for innovative ways to lower our CLABSI rate, and the use of Clorhexidine/Silver Sulfadiazine catheters was unable to move our CLABSI rate. We decided to try Minocycline/Rifampin catheters, and monitor our Central Line-Associated Bloodstream Infection rate.
Medical Research: What should clinicians and patients take away from your report?
Response: The use of Minocycline/Rifampin impregnated catheters can lower Central Line-Associated Bloodstream Infection rate, particularly in ICUs who have been unable to reach a Central Line-Associated Bloodstream Infection rate of zero with other measures.
Medical Research: What recommendations do you have for future research as a result of this study?
Response: Future research could include larger scale studies of this product, as well as studying the effects of other types of antibiotic impregnated catheters, like peripherally inserted central catheters.
Citation:
Journal of the American College of Surgeons
[wysija_form id=”3″]
MedicalResearch.com Interview with: Stephanie Bonne, MD, FACS Assistant Professor, Trauma, Acute, and Critical Care Surgery, Washington University in St. Louis (2015). Antibiotic Impregnated Catheters Can Reduce Central Line-Associated Bloodstream Infection
Last Updated on June 8, 2015 by Marie Benz MD FAAD